Back to FIRST TRUST ADVISORS LP FIRST TRUST ADVISORS LP

NBIXNBIX
Showing 8 of 30 quarters

Position history for FIRST TRUST ADVISORS LPFIRST TRUST ADVISORS LP's holdings in NEUROCRINE BIOSCIENCES INC

FIRST TRUST ADVISORS LP holds 959,217 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $126.4M as of 2026-Q1. The position was increased (+97.0% shares). NBIX represents 0.1% of FIRST TRUST ADVISORS LP's portfolio.

Current Value

$126.4M

Current Shares

959,217

Total Value Change

+$66.7M

Total Shares Change

+525,680

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
959,217
+97.0%
$126.4M0.1%$131.14
48
2025-Q4
Increased
486,809
+34.1%
$69M0.1%$140.95
38
2025-Q3
Decreased
363,113
-14.3%
$51M0.0%$140.27
0
2025-Q2
Decreased
423,471
-28.6%
$53.2M0.0%$125.42
0
2025-Q1
Increased
593,355
+50.4%
$65.6M0.1%$113.16
41
2024-Q4
Decreased
394,652
-27.5%
$53.9M0.0%$137.06
0
2024-Q3
Increased
544,321
+25.6%
$62.7M0.1%$115.06
36
2024-Q2
Decreased
433,537
-17.7%
$59.7M0.1%$137.67
0

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used